.
BMS 986120
Originator Bristol-Myers Squibb
Phase I Thrombosis
- 02 Apr 2015 Bristol-Myers Squibb plans a phase I trial in Thrombosis (In volunteers) in United Kingdom (NCT02439190)
- 01 Aug 2014 Preclinical trials in Thrombosis in USA (PO)
https://clinicaltrials.gov/ct2/show/NCT02208882
https://clinicaltrials.gov/ct2/show/NCT02439190
Class Imidazoles; Small molecules; Thiadiazoles
$BMY antithrombic compound
all data coming……………
////////BMS 986120, phase 1, Bristol-Myers Squibb , Imidazoles, Small molecules, Thiadiazoles
